ReviewActa pharmacologica Sinica2022
Chemistry and bioactivity of secondary metabolites from South China Sea marine fauna and flora: recent research advances and perspective.
Review in Acta pharmacologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Cembrane- and Casbane-Type Diterpenes from the South China Sea Soft CoralMarine drugs · 2026Article
- Review
- New Bioactive Eudesmane-type Sesquiterpenoids From the Red Sea Soft Coral Nephthea sp.Chemistry & biodiversity · 2026Article
- Bioprospecting of Marine Organisms: Exploring Antibacterial Activities in Aqueous and Organic Extracts.Microorganisms · 2025Article
- Antibacterial Methyl Ester Cembranoids from the Soft CoralMarine drugs · 2025Article
- Polyoxygenated cembrane-type diterpenes from the Hainan soft coral Lobophytum crassum as a promising source of anticancer agents with ErbB3 and ROR1 inhibitory potential.Acta pharmacologica Sinica · 2025Article
- Two New Diterpenoids Formed by Transannular Diels-Alder Cycloaddition from the Soft CoralMarine drugs · 2024Article
- Cembranoid Diterpenes from South China Sea Soft CoralMarine drugs · 2024Article
- Immunomodulatory Compounds from the Sea: From the Origins to a Modern Marine Pharmacopoeia.Marine drugs · 2024Review
- In Vitro Insights into the Role of 7,8-Epoxy-11-Sinulariolide Acetate Isolated from Soft CoralMarine drugs · 2024Article
- Nine New Antibacterial Diterpenes and Steroids from the South China Sea Soft CoralMarine drugs · 2024Article
- Article
- Structurally Diverse Diterpenes from the South China Sea Soft CoralMarine drugs · 2023Article
- Cembrane Diterpenes Possessing Nonaromatic Oxacycles from the Hainan Soft CoralInternational journal of molecular sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marine organisms often produce a variety of metabolites with unique structures and diverse biological activities that enable them to survive and struggle in the extremely challenging environment. During the last two decades, our group devoted great effort to the discovery of pharmaceutically interesting lead compounds from South China Sea marine plants and invertebrates. We discovered numerous marine secondary metabolites spanning a wide range of structural classes, various biosynthetic origins and various aspects of biological activities. In a series of reviews, we have summarized the bioactive natural products isolated from Chinese marine flora and fauna found during 2000-2012. The present review provides an updated summary covering our latest research progress and development in the last decade (2012-2022) highlighting the discovery of over 400 novel marine secondary metabolites with promising bioactivities from South China Sea marine organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.